Evidence map›Paper›PMID 36050845›Full record

ArticleASN neuro

Dopamine D

Ernesto Alberto Rendón-Ochoa, Montserrat Padilla-Orozco, Vladimir Melesio Calderon, Victor Hugo Avilés-Rosas, Omar Hernández-González, Teresa Hernández-Flores, María Belén Perez-Ramirez, Marcela Palomero-Rivero, Elvira Galarraga, José Bargas

Open access · goldAbstract read
In one paragraph

Article in ASN neuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Adenosine AFrontiers in pharmacology · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Ernesto Alberto Rendón-OchoaLaboratorio de Psicofarmacología, Unidad de Investigación Interdisciplinaria y de Ciencias de la Salud y Educación, Facultad de Estudios Superiores Iztacala, 61739Universidad Nacional Autónoma de México, Tlalnepantla, Mexico.
Montserrat Padilla-OrozcoDivisión de Neurociencias, Instituto de Fisiología Celular, 61739Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico.
Vladimir Melesio CalderonDivisión de Neurociencias, Instituto de Fisiología Celular, 61739Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico.ORCID 0000-0002-4376-6677
Victor Hugo Avilés-RosasDivisión de Neurociencias, Instituto de Fisiología Celular, 61739Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico.
Omar Hernández-GonzálezFacultad de Medicina, Departamento dé Fisiología, 61739Universidad Nacional Autónoma de México, Circuito Exterior s/n Ciudad Universitaria, Ciudad de Mexico, Mexico.
Teresa Hernández-FloresBrain Mechanism for behavior Unit, 508336Okinawa Institute of Science and Technology, Okinawa, Japan.
María Belén Perez-RamirezDivisión de Neurociencias, Instituto de Fisiología Celular, 61739Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico.
Marcela Palomero-RiveroDivisión de Neurociencias, Instituto de Fisiología Celular, 61739Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico.
Elvira GalarragaDivisión de Neurociencias, Instituto de Fisiología Celular, 61739Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico.
José BargasDivisión de Neurociencias, Instituto de Fisiología Celular, 61739Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico.ORCID 0000-0002-8205-8163
Universidad Nacional Autónoma de México · MXAutonomous University of Tlaxcala · MXOkinawa Institute of Science and Technology Graduate University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

summary statementA

Indexed as

DopamineParkinsonian DisordersAdenosineAnimalsPramipexoleReceptors, Dopamine D2RodentiaAdenosineDopaminePramipexoleReceptors, Dopamine D2adenosine A2A receptorcalcium imagingdopamine D2 receptoristradefyllineParkinson’s diseasepramipexole

Identifiers

PMID36050845
PMCPMC9178983
OpenAlexW4285246185

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.